Literature DB >> 17353253

Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion.

F A A Gondim1, E A De Sousa, N Latov, H W Sander, R L Chin, T H Brannagan.   

Abstract

Patients with anti-myelin associated glycoprotein (anti-MAG) neuropathy have uniform slowing without temporal dispersion, but do usually have disproportionately distal slowing. We evaluated distal compound muscle action potential (CMAP) dispersion in 29 patients with anti-MAG/sulphated glucuronyl paragloboside (SGPG) neuropathy (titres > or = 12,800). Among 138 motor responses, 15% (tibial), 7.3% (peroneal), 10.7% (median) and 13.8% (ulnar) had distal CMAP duration > 9 ms. Disproportionate distal slowing with normal distal CMAP duration in the arms may be useful to differentiate chronic inflammatory demyelinating polyneuropathy from anti-MAG/SGPG associated neuropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353253      PMCID: PMC2117731          DOI: 10.1136/jnnp.2006.111930

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.

Authors:  Pariwat Thaisetthawatkul; Eric L Logigian; David N Herrmann
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

Review 2.  Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

Review 3.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  C Briani; T H Brannagan; W Trojaborg; N Latov
Journal:  Neuromuscul Disord       Date:  1996-10       Impact factor: 4.296

4.  Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins.

Authors:  E Nobile-Orazio; P Marmiroli; L Baldini; G Spagnol; S Barbieri; M Moggio; N Polli; E Polli; G Scarlato
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

5.  Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing.

Authors:  Michael P T Lunn; Thomas O Crawford; Richard A C Hughes; John W Griffin; Kazim A Sheikh
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

6.  Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein.

Authors:  A H Tatum
Journal:  Ann Neurol       Date:  1993-05       Impact factor: 10.422

7.  Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.

Authors:  Paul Magda; Norman Latov; Thomas H Brannagan; Louis H Weimer; Russell L Chin; Howard W Sander
Journal:  Arch Neurol       Date:  2003-12

8.  Immune reactive C3d on the surface of myelin sheaths in neuropathy.

Authors:  A P Hays; S S Lee; N Latov
Journal:  J Neuroimmunol       Date:  1988-06       Impact factor: 3.478

9.  Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside.

Authors:  D A Kaku; J D England; A J Sumner
Journal:  Brain       Date:  1994-10       Impact factor: 13.501

10.  Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

Authors:  D J Lange; W Trojaborg; N Latov; A P Hays; D S Younger; A Uncini; D M Blake; M Hirano; S M Burns; R E Lovelace
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

View more
  1 in total

1.  Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report.

Authors:  Minori Kodaira; Kanji Yamamoto
Journal:  Case Rep Neurol       Date:  2013-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.